Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Consumer Stocks Rise Late Afternoon

Sector Update: Consumer Stocks Rise Late Afternoon

MT newswireMT newswire2026/10/05 19:37

03:37 PM EDT, 10/05/2026 (MT Newswires) -- Consumer stocks were higher late Monday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) increasing 0.5% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) adding 0.6%. In corporate news, McDonald's (MCD) is facing a proposed class-action lawsuit alleging it used an algorithm-driven pricing tool to fix menu prices across its US restaurants, according to a complaint filed in federal court. Its shares were up 0.2%. Neighborhood Intelligence (NXH) said Monday it has agreed to sell nearly 16.5 million shares at $2.76 per share, or pre-funded warrant in lieu, in a registered direct offering. The company, previously known as Bed Bath & Beyond, said that in addition it will issue warrants to buy up to about 16.1 million shares. Separately, Neighborhood Intelligence and Fathom's (FTHM) boards have mutually agreed to terminate their planned merger, the company said. Neighborhood Intelligence shares fell 25%. Walmart (WMT) and Alphabet (GOOGL) unit Wing plan to expand their drone delivery service to the Denver and Seattle metropolitan areas in 2027. The additions will bring the service to nearly 20 US metro areas with plans to reach more than 270 Walmart stores nationwide, Wing said Monday. Walmart shares rose 0.7%. Paramount Skydance (PSKY) Chairman and Chief Executive David Ellison will be chairman and CEO of the combined company following the anticipated close of Paramount's acquisition of Warner Bros. Discovery (WBD), Paramount said. Paramount shares were up 2.8%, and Warner Bros. increased 0.2%.

03:37 PM EDT, 10/05/2026 (MT Newswires) -- Consumer stocks were higher late Monday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) increasing 0.5% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) adding 0.6%. In corporate news, McDonald's (MCD) is facing a proposed class-action lawsuit alleging it used an algorithm-driven pricing tool to fix menu prices across its US restaurants, according to a complaint filed in federal court. Its shares were up 0.2%. Neighborhood Intelligence (NXH) said Monday it has agreed to sell nearly 16.5 million shares at $2.76 per share, or pre-funded warrant in lieu, in a registered direct offering. The company, previously known as Bed Bath & Beyond, said that in addition it will issue warrants to buy up to about 16.1 million shares. Separately, Neighborhood Intelligence and Fathom's (FTHM) boards have mutually agreed to terminate their planned merger, the company said. Neighborhood Intelligence shares fell 25%. Walmart (WMT) and Alphabet (GOOGL) unit Wing plan to expand their drone delivery service to the Denver and Seattle metropolitan areas in 2027. The additions will bring the service to nearly 20 US metro areas with plans to reach more than 270 Walmart stores nationwide, Wing said Monday. Walmart shares rose 0.7%. Paramount Skydance (PSKY) Chairman and Chief Executive David Ellison will be chairman and CEO of the combined company following the anticipated close of Paramount's acquisition of Warner Bros. Discovery (WBD), Paramount said. Paramount shares were up 2.8%, and Warner Bros. increased 0.2%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ-Genmab shares hit a three-year high as blood cancer drug combination study results are released

October 6 - Genmab (GMAB.CO) shares rose about 8%, reaching a three-year high and leading the STOXX 600 index (.STOXX). Genmab and AbbVie ABBV.N announced on Monday (link) that their combination therapy for blood cancer reduced the risk of disease progression and death in a late-stage clinical trial. The two companies stated that, compared to R-CHOP regimen alone, the combination therapy reduced the risk of disease progression or death in newly diagnosed patients by 51%. Analysts at Jefferies described this result as "impressive". The brokerage added that the data "easily met the bar for success" and exceeded investor expectations of approximately 40%. TD Cowen stated that the data establishes the combination therapy as a potential new standard of care, with peak market potential expected to exceed $3 billion. (For convenience of non-English speakers, Reuters has automated this report into several other languages. Automated translations may contain errors or lack necessary context, and Reuters makes no guarantees as to their accuracy. The automated translation is provided for reader convenience, and Reuters bears no responsibility for any damages or losses resulting from use of the automated translation.)

路透社•2026/10/06 07:26